Page 62 - Read Online

Page 16 of 16 Liu et al. Hepatoma Res 2020;6:7 I http://dx.doi.org/10.20517/2394-5079.2019.39

71. Nakagawa H, Umemura A, Taniguchi K, Font-Burgada J, Dhar D, et al. ER stress cooperates with hypernutrition to trigger TNF-
dependent spontaneous HCC development. Cancer Cell 2014;26:331-43.
72. Shalapour S, Lin XJ, Bastian IN, Brain J, Burt AD, et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature
2017;551:340-5.
73. Molina-Sánchez P, Lujambio A. Iron overload and liver cancer. J Exp Med 2019;216:723.
74. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, et al. HFE gene knockout produces mouse model of hereditary
hemochromatosis. Proc Natl Acad Sci U S A 1998;95:2492-7.
75. Pigeon C, Turlin B, Iancu TC, Leroyer P, Lan JL, et al. Carbonyl-ironsupplementationinduces hepatocyte nuclear changes in BALB/CJ
male mice. J Hepatol 1999;30:926-34.
76. Rothenberg BE, Voland JR. β2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major
histocompatibility complex in ironmetabolism. Proc Natl Acad Sci U S A 1996;93:1529-34.
77. Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, et al. Disruption of FBXL5-mediated cellular iron homeostasis promotes liver
carcinogenesis. J Exp Med 2019;216:950-65.
78. Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev
Gastroenterol Hepatol 2018;15:397-411.
79. Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol
2017;14:527-39.
80. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through
senescence secretome. Nature 2013;499:97-101.
81. Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, et al. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient
high-fat diet-induced NASH mouse model. Biochem Biophys Res Commun 2016;470:15-21.
82. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and
TLR4. Cancer Cell 2012;21:504-16.
83. Poutahidis T, Varian BJ, Levkovich T, Lakritz JR, Mirabal S, et al. Dietary microbes modulate transgenerational cancer risk. Cancer Res
2015;75:1197-204.
84. Llopis M, Cassard AM, Wrzosek L, Boschat L, Bruneau A, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic
liver disease. Gut 2016;65:830-9.
85. Xu W, Liu K, Chen M, Sun JY, McCaughan GW, et al. Immunotherapy for hepatocellular carcinoma: recent advances and future
perspectives. Ther Adv Med Oncol 2019;11:1758835919862692.